INDOCO — INDOCO REMEDIES Income Statement
0.000.00%
Last trade - 00:00
- IN₹30.85bn
- IN₹35.00bn
- IN₹16.69bn
- 76
- 26
- 30
- 37
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 9,684 | 11,066 | 12,415 | 15,408 | 16,686 |
Cost of Revenue | |||||
Gross Profit | 6,069 | 7,265 | 8,345 | 10,184 | 10,787 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 9,632 | 10,539 | 10,901 | 12,918 | 14,517 |
Operating Profit | 52.9 | 526 | 1,514 | 2,489 | 2,169 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -93.1 | 286 | 1,320 | 2,366 | 1,928 |
Provision for Income Taxes | |||||
Net Income After Taxes | -29 | 241 | 930 | 1,548 | 1,423 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -29 | 241 | 930 | 1,548 | 1,423 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -29 | 241 | 930 | 1,548 | 1,423 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.28 | 2.9 | 10.1 | 17 | 15.5 |
Dividends per Share | |||||
Special Dividends per Share |